Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05342155 · ClinicalTrials.gov registry record
Patient- Generated Health Data to Predict Childhood Cancer Survivorship Outcomes
A clinical trial of Survivorship and Childhood Cancer, sponsored by St. Jude Children's Research Hospital.
- Active
- Registry status
- 602
- Enrollment target
- 1
- Study location
NCT05342155: Active study of Survivorship and Childhood Cancer, sponsored by St. Jude Children's Research Hospital.
NCT05342155 is a study of Survivorship and Childhood Cancer that is active but no longer recruiting, run by St. Jude Children's Research Hospital. The registered enrollment target is 602 participants, above the 213-participant average among 36 other Survivorship trials with a reported enrollment target (183% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05342155, a study of Survivorship and Childhood Cancer, is active but no longer recruiting, sponsored by St. Jude Children's Research Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 602 participants
- Enrollment target
- 1
- Study location
Study Summary
Some childhood cancer survivors have health problems as the result of previous cancer treatment. This study is being done to determine if we can better predict the risk a childhood cancer survivor might have for developing future health issues. The goal of this study is to enable regular monitoring of patient-generated health data (PGHD), including symptoms, physical activity, energy expenditure, sleep behavior and heart rate variability, and utilize these data in predicting survivor-specific risk of late effects to improve survivorship care and outcomes.
Primary Outcome
Log of patient reported symptoms
Conditions Studied
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 602 participants |
| Start Date | 2023-03-20 |
| Est. Completion | 2028-06-20 |
What the registry record for NCT05342155 still lists
NCT05342155 is an observational study that tracks outcomes without assigning an intervention. The registered 602 participants enrollment target is mid-sized for trials with a published cap, above the 213-participant average among 36 other Survivorship trials with a reported enrollment target (183% higher).
The record links to 2 conditions, with Survivorship appearing as the primary indexed condition, and to 0 interventions.
NCT05342155 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT05342155 about?
NCT05342155 is a clinical study titled "Patient- Generated Health Data to Predict Childhood Cancer Survivorship Outcomes". Some childhood cancer survivors have health problems as the result of previous cancer treatment. This study is being done to determine if we can better predict the risk a childhood cancer survivor might have for developing future health issues. The goal of this study is to enable regular monitoring...
What is the current status of trial NCT05342155?
This trial is currently active not recruiting. The enrollment target is 602 participants. The study started on 2023-03-20. Estimated completion is 2028-06-20.
What conditions does trial NCT05342155 study?
This clinical trial studies the following conditions: Survivorship, Childhood Cancer.
Who is sponsoring clinical trial NCT05342155?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05342155 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Survivorship
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05342155's enrollment target sits among peer trials
602 5th of 36 higher than 32 of 36 other Survivorship trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Survivorship trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Sleep Treatment Education Program for Cancer Survivors: STEP-Together
RECRUITING · NA
-
Dance Study for Post-surgical Pain in Breast Cancer Survivors
RECRUITING · NA
-
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
RECRUITING · Phase 2
-
Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
RECRUITING · NA
-
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03849443 · 604 participants · Early Phase 1
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
- NCT05238922 · 604 participants · Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- NCT06040541 · 604 participants · Phase 1
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI